Abstract
1019^ Background: Patients (pts) with triple negative breast cancer (TNBC) who have residual disease after preoperative chemotherapy have a high risk of recurrence. No standard systemic therapy has...
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Paper version not known
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
